Graham Capital Management, L.P. Krystal Biotech, Inc. Transaction History
Graham Capital Management, L.P.
- $4.38 Billion
- Q1 2025
A detailed history of Graham Capital Management, L.P. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 2,179 shares of KRYS stock, worth $331,382. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,179
Previous 2,082
4.66%
Holding current value
$331,382
Previous $326,000
20.25%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding KRYS
# of Institutions
329Shares Held
24.3MCall Options Held
299KPut Options Held
97.6K-
Black Rock Inc. New York, NY3.95MShares$600 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.83MShares$430 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.73MShares$415 Million7.97% of portfolio
-
State Street Corp Boston, MA1.23MShares$187 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA954KShares$145 Million0.03% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.9B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...